Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Susan Onami"'
Autor:
Susan Onami, Duc Tran, Christine Koh-Pham, Wendy Shih, Bradley Chi, Jiahao Peng, David Shavlik, Pramil Singh, Joseph Giacino
Publikováno v:
Archives of Physical Medicine and Rehabilitation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53ebf852cfb7dc287710da9d48b5cf11
https://doi.org/10.1016/j.apmr.2023.01.007
https://doi.org/10.1016/j.apmr.2023.01.007
Publikováno v:
Maturitas. 67:209-214
Endocrine therapy in the setting of breast cancer has undoubtedly advanced clinical outcomes in this disease, but treatment with endocrine therapy is accompanied by a wide spectrum of side effects. It is of prime importance to understand and characte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8db0abbf1bb2c2d1f6a45967d711d982
https://doi.org/10.1016/j.maturitas.2010.07.004
https://doi.org/10.1016/j.maturitas.2010.07.004
Autor:
Sarah Waliany, Laura Kruper, Susan Onami, Joanne E. Mortimer, Sumanta K. Pal, JoAnn Hsu, Mary Dehaven, Rebecca A. Nelson
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 435 (2012)
BMC Cancer
BMC Cancer
Background Data that directly associate utilization of novel systemic therapies with survival trends in metastatic breast cancer (MBC) are limited. In the setting of de novo MBC, large registry analyses cite positive temporal trends in survival, but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86eb6a4df7769dde5bc5af0a583c4596
https://doi.org/10.1186/1471-2407-12-435
https://doi.org/10.1186/1471-2407-12-435
Significant advances have been made in the diagnosis and treatment of female breast cancer, resulting in a decline in incidence and a global improvement in clinical outcome. The statistics for male breast cancer (MBC) stand in sharp contrast – over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3aba9ddc3c284a556d6b50d40cc779e
https://europepmc.org/articles/PMC3253821/
https://europepmc.org/articles/PMC3253821/
Autor:
Susan Onami
Publikováno v:
Onami, Susan. (2010). The Aging Brain: Are two pathologies worse than one? White matter hyperintensities, beta-amyloid, and cognition in normal elderly. Berkeley Scientific Journal, 13(2). Retrieved from: http://www.escholarship.org/uc/item/74d2c80k
White matter hyperintensities (WMH)—areas of increased signal on T2 and Fluid Attenuated Inversion Recovery (FLAIR) MRI images—and beta-amyloid (ABeta) plaques—an Alzheimer’s disease pathology—are commonly found in the brains of cognitively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08dc04a18127cd7754a72e52583dfc73
https://doi.org/10.5070/bs3132007631
https://doi.org/10.5070/bs3132007631
Autor:
Chao Guo, Sharon P. Wilczynski, Hanlin Gao, Yuping Li, Xuejun Li, Robert A. Figlin, Jennifer M. Jin, Nora Ruel, Maricela Covarrubias, Bing Mu, Xiwei Wu, Susan Onami, Lawrence M. Weiss, Huiqing Wu, Rebecca A. Nelson, Lihong Weng, Jeffrey J. Wu, Sumanta K. Pal
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 5, p e35661 (2012)
PLoS ONE, Vol 7, Iss 5, p e35661 (2012)
Renal cell carcinoma (RCC) metastasis portends a poor prognosis and cannot be reliably predicted. Early determination of the metastatic potential of RCC may help guide proper treatment. We analyzed microRNA (miRNA) expression in clear cell RCC (ccRCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::154400f5506a2c806a3f5d2ee2d4d512
https://doi.org/10.1371/journal.pone.0035661
https://doi.org/10.1371/journal.pone.0035661
Publikováno v:
Maturitas. 66:220
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d32fa19544d0d622de5b27693cf6e952
https://doi.org/10.1016/j.maturitas.2010.04.003
https://doi.org/10.1016/j.maturitas.2010.04.003
Autor:
Huiqing Wu, Bing Mu, Nora Ruel, Maricela Covarrubias, Xuejun Li, Sumanta K. Pal, Jennifer M. Jin, Lihong Weng, Hanlin Gao, Xiwei Wu, Lawrence M. Weiss, Rebecca A. Nelson, Susan Onami, Robert A. Figlin, Chao Guo
Publikováno v:
Cancer Research. 70:LB-275
Introduction: Clear cell renal cell carcinoma (ccRCC) represents the most common renal cancer histology. In the setting of metastatic disease, few patients achieve a durable remission with currently available therapies. Early determination of metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b77773f7c8e573e525431b6885b0c8c
https://doi.org/10.1158/1538-7445.am10-lb-275
https://doi.org/10.1158/1538-7445.am10-lb-275